The BMJ is well-known for its annual Christmas issue, which New York Times medical correspondent Lawrence Altman calls
a lighter and sometimes brighter side of medicine, publishing unusual articles that vary from simply amusing to bizarre to creative or potentially important.
Here’s a retraction from Stem Cells and Development that we’re just now getting around to covering. The paper, “Non-viral reprogramming of skeletal myoblasts with valproic acid for pluripotency,” appeared in June 2012 in a preliminary online form and was written by a group at the University of Cincinnati. As the retraction notice states: Continue reading Retraction for stem cell scientist facing misconduct inquiry
Ariel Fernández, the protein researcher whose theories of drug design lately have come in for questioning, has lost a paper, at least for the moment.
The article, “Supramolecular Evolution of Protein Organization,” appeared online in Annual Reviews of Genetics prior to print. It lists Fernández’s affiliation as ProWD Sciences, in Madison, Wisc. Not much exists on the web about that company, however, except an under-construction site. (ProWD, by the way, is short for PROtein-Water-Dehydron, Fernández’s area of interest.)
Analytical Letters has retracted a 2011 article by a chemistry researcher at Wright State University in Dayton, Ohio, who seems to have avoided giving credit where credit was due.
The article, “Conducting Polymer Matrix Poly(2,2′-bithiophene) Mercury Metal Incorporation,” was written (so readers were told) by Suzanne Lunsford.
Not so, it seems, with a certain Darrel Montero. Montero, an associate professor in the School of Social Work at Arizona State University, and his colleagues have lost their 2012 paper in the journal for what appears to be a case of data theft.
The Journal of Pediatric Nursing has retracted a 2013 article (meeting abstract, really) on growth hormone after the drug company that employed the authors cried “take it back.”
The research appears to have been presented at a meeting of the Pediatric Endocrinology Nursing Society, and looked at inefficiency in the use of devices for administering growth hormone. All but one of the authors is listed as working for Novo Nordisk, an international pharmaceutical firm.
Nitin Aggarwal, formerly of the Medical College of Wisconsin, faked data in his PhD thesis, grant applications to the NIH and American Heart Association, and in two papers, according to new findings by the Office of Research Integrity.
(The case would have apparently first been published in the Federal Register on October 2, except for the government shutdown.)
On Wednesday, we brought you the story of a retraction by Gerold Feuer, a State University of New York (SUNY) Upstate Medical Center stem cell scientist whom the university had found to have misused grants. He was suspended, but successfully fought that action. We had asked Feuer for comment at that time, and he has now responded:
SUNY Upstate Medical University’s decision to widely publicize the recent decision by the journal Stem Cells to retract an article from my laboratory is a vindictive and retaliatory campaign to defame my scientific credentials in the press and to my scientific colleagues.
I unequivocally state that the data in all published manuscripts is valid and sound and is not falsified or fabricated. SUNY UMU unilaterally requested a retraction from Stem Cells, despite the fact that the federal Office of Research Integrity (ORI) has not yet ruled on these allegations. It is not surprising that UMU has decided to publicize this retraction in a public forum as a second attempt to force me from my tenured faculty position and circumvent decision of the employment arbitrator and the New York Supreme Court.
